New agreement to facilitate genetic diagnosis of hereditary retinal dystrophies

An agreement between the University of Barcelona spin-off DBGen Ocular Genomics and the company Novartis España will enable the genetic identification of retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA) in affected patients.

Related Keywords

Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Novartis Espa ,Megan Craig ,Rebeca Valero ,Roser Gonz ,Gemma Marfany ,European Union ,Novartis ,Department Of Genetics ,University Of Barcelona ,Institute Of Biomedicine ,Ocular Genomics ,Eye ,Genes ,Gene ,Enetic ,Genomics ,Leber Congenital Amaurosis ,Retinitis Pigmentosa ,